ORIGINAL RESEARCH
Accepted on 10 Sep 2025
Cost-Effectiveness of Cadonilimab Plus Chemotherapy vs Chemotherapy Alone for Advanced Gastric Cancer: Evidence to Inform Drug Pricing in the U.S. and China
doi 10.3389/fimmu.2025.1618726
- 208 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Checkpoint Immunotherapy: Reshaping the Landscape of Gastrointestinal Cancer Treatment
Checkpoint Immunotherapy: Reshaping the Landscape of Gastrointestinal Cancer Treatment
10k
Total downloads
48k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 01 Sep 2025
Liquid-liquid phase separation in gastric cancer: identifying novel biomarkers and therapeutic targets through gene signature analysis
doi 10.3389/fimmu.2025.1620390
- 1,321 views
ORIGINAL RESEARCH
Published on 27 Aug 2025
Efficacy and safety of postoperative adjuvant HAIC combining lenvatinib with or without PD-1 inhibitors in solitary large HCC: A multicenter retrospective study
doi 10.3389/fimmu.2025.1609352
- 875 views
ORIGINAL RESEARCH
Published on 18 Jul 2025
Additions of trastuzumab to preoperative chemotherapy or chemoimmunotherapy for patients with potentially resectable stage III to IVB HER2-positive gastric cancer
doi 10.3389/fimmu.2025.1624943
- 1,303 views
CASE REPORT
Published on 18 Jul 2025
Case Report: Pathological complete response achieved with neoadjuvant immunochemotherapy in synchronous multiple gastric adenocarcinoma
doi 10.3389/fimmu.2025.1611281
- 1,027 views
CASE REPORT
Published on 27 Jun 2025
Hyperbaric oxygen therapy as an immunosensitizing strategy in advanced gastric hepatoid adenocarcinoma: a case report
doi 10.3389/fimmu.2025.1625273
- 1,401 views
ORIGINAL RESEARCH
Published on 13 May 2025
Cost-effectiveness analysis of first-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma
doi 10.3389/fimmu.2025.1575627
- 1,927 views
- 3 citations
ORIGINAL RESEARCH
Published on 25 Apr 2025
In vivo RNAi screen and validation reveals Ngp, Hba-a1, and S100a8 as novel inhibitory targets on T lymphocytes in liver cancer
doi 10.3389/fimmu.2025.1549229
- 2,207 views
ORIGINAL RESEARCH
Published on 31 Mar 2025
Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study
doi 10.3389/fimmu.2025.1493234
- 2,054 views
- 1 citation
STUDY PROTOCOL
Published on 25 Feb 2025
Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial
doi 10.3389/fimmu.2025.1519545
- 3,366 views
- 1 citation
SYSTEMATIC REVIEW
Published on 27 Jan 2025
Neoadjuvant immunotherapy for DNA mismatch repair proficient/microsatellite stable non-metastatic rectal cancer: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1523455
- 4,349 views
- 3 citations
CASE REPORT
Published on 08 Jan 2025
Hepatoid adenocarcinoma of the stomach with ideal response to neoadjuvant chemo-immunotherapy: a case report
doi 10.3389/fimmu.2024.1496342
- 1,472 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore